Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giario Conti

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Pathologica|January 4, 2021
Invasion and metastasis: a historical perspectiveCarlo Patriarca, Giacomo Maria Pini, Giario Conti
BJU International|March 30, 2010
New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classificationPaolo Puppo, Giario Conti, Francesco Francesca, et al.
Current Medical Research and Opinion|June 26, 2007
Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summarySebastiano Spatafora, Giario Conti, Massimo Perachino, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancerFrancesco Boccardo, Alessandra Rubagotti, Giario Conti, et al.
Oncology|August 21, 2008
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trialFrancesco Boccardo, Alessandra Rubagotti, Giario Conti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2016
Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizonsLaura Evangelista, Francesco Bertoldo, Francesco Boccardo, et al.
International Journal of Surgical Pathology|March 22, 2014
Whorled Urothelial Cell Carcinoma: A Neglected VariantCarlo Patriarca, Eva Comperat, Enrico Bollito, et al.
Urologic Oncology|April 28, 2009
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladderSarel Halachmi, Boaz Moskovitz, Massimo Maffezzini, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 8, 2008
Prostate cancer metastases to bone: observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline featuresGiario Conti, Giuseppe La Torre, Virgilio Cicalese, et al.
Future Oncology (London, England)|June 16, 2018
Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of careGiuseppe De Vincentis, Fabio Monari, Sergio Baldari, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pathologica|January 4, 2021
Invasion and metastasis: a historical perspectiveCarlo Patriarca, Giacomo Maria Pini, Giario Conti
BJU International|March 30, 2010
New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classificationPaolo Puppo, Giario Conti, Francesco Francesca, et al.
Current Medical Research and Opinion|June 26, 2007
Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summarySebastiano Spatafora, Giario Conti, Massimo Perachino, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancerFrancesco Boccardo, Alessandra Rubagotti, Giario Conti, et al.
Oncology|August 21, 2008
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trialFrancesco Boccardo, Alessandra Rubagotti, Giario Conti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2016
Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizonsLaura Evangelista, Francesco Bertoldo, Francesco Boccardo, et al.
International Journal of Surgical Pathology|March 22, 2014
Whorled Urothelial Cell Carcinoma: A Neglected VariantCarlo Patriarca, Eva Comperat, Enrico Bollito, et al.
Urologic Oncology|April 28, 2009
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladderSarel Halachmi, Boaz Moskovitz, Massimo Maffezzini, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 8, 2008
Prostate cancer metastases to bone: observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline featuresGiario Conti, Giuseppe La Torre, Virgilio Cicalese, et al.
Future Oncology (London, England)|June 16, 2018
Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of careGiuseppe De Vincentis, Fabio Monari, Sergio Baldari, et al.
Pageof 3